潮州看白癜风专科哪家很好(汕尾哪里看儿童白癜风最好) (今日更新中)

ATLANTA, Ga. (AP) — A section of concrete collapsed on a parking deck under construction in Atlanta on Friday, injuring five workers.Atlanta Fire Rescue officials said one worker was trapped under debris with leg injuries and had to be freed and then lowered more than nine stories to the ground using a construction crane.Four other injured workers managed to walk away from the accident.The city of Atlanta is inspecting the structure for any signs of threats to the busy interstate that flows through the heart of the city.The parking garage is being built for an Emory University cancer institute in midtown.W Peachtree Street @ Linden Ave, partial #collapse of pre-fabricated parking deck under construction. Multiple workers trapped. Injured worker just removed from structure by firefighters from Squad 4 by crane. #AFRD— Atlanta Fire Rescue (@ATLFireRescue) September 11, 2020 893

AUSTIN, Texas (AP) — Authorities say two cranes collided and at least partially collapsed at a construction site in Austin, Texas, injuring at least 22 people. Footage posted by TV station KVUE after Wednesday's accident shows two cranes tangled several stories above a building under construction a few miles north of downtown in a rapidly growing neighborhood that includes residential, retail and office space. TV footage showed one of the crane operators still inside the crane cabin, although it did not appear to be damaged.Austin-Travis County EMS reports that at least 22 people were hurt, including at least seven who were being treated and prepped for transport to a hospital. At least eight ambulances were headed to the scene. 746

ATLANTA (AP) — Early in-person voting began Monday in Georgia for the state's two U.S. Senate runoffs.The early voting period runs as late as Dec. 31 in some counties.It could determine the outcome of the races between Republican U.S. Sens. David Perdue and Kelly Loeffler and Democratic challengers Jon Ossoff and Raphael Warnock.A majority of votes before the Nov. 3 general election were cast in person during early voting.The period could be even more important during the runoffs because of the shortened period for voters to request and return ballots by mail.More than 125,000 people cast ballots in October on the first day of early voting. Lines were long then and could be long again Monday. 709

At this point, a day or two without power seems like just a minor inconvenience. Maybe some spoiled milk in the fridge. Or the frustration of a drained cellphone.But much of eastern Florida hasn't had electricity since last weekend. And parts of the state's battered west coast might not get power for another 10 days.The danger was exemplified Wednesday, when eight people died in Hollywood, Florida, after their nursing home lost air conditioning. The residents' causes of death are being investigated."I'm afraid the death toll from Irma is not over yet," said Craig Fugate, former administrator of the Federal Emergency Management Agency. Fugate himself had no power Wednesday in his Gainesville home.Electricity can literally be a lifeline, powering everything from hospitals to oxygen tanks.So, what will 10 days without power look like? Here's what to expect, and what to do about it: 904

As questions arise over when a coronavirus vaccine should be granted FDA approval, the leaders of several major pharmaceutical companies announced they have signed a pledge not to rush the development of a vaccine.The companies, AstraZeneca, BioNTech, GlaxoSmithKline, Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi, released a joint statement on Tuesday confirming the pledge.The pledge includes the following points:Always make the safety and well-being of vaccinated individuals our top priority.Continue to adhere to high scientific and ethical standards regarding the conduct of clinical trials and the rigor of manufacturing processes.Only submit for approval or emergency use authorization after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA.Work to ensure a sufficient supply and range of vaccine options, including those suitable for global access.There has been pressure on both the FDA and manufactures to develop and approve a vaccine for the coronavirus. There have been more than 190,000 coronavirus-related deaths in the US since March, and the economic impact of the virus has cost millions of jobs.While most developed countries have not had the same public health pain as the US, the economic impact of the virus has been felt worldwide. The International Monetary Fund estimates a nearly 5% loss in global GDP in 2020.In Russia, the country claimed to begin distributing a coronavirus vaccine despite US-based vaccine candidates likely being months away from being able to demonstrate efficacy.The pressure domestically has also ratcheted up as President Donald Trump has suggested a vaccine could be ready by this fall’s presidential election."We're going to have a vaccine very soon... maybe even before a very special date, you know what date I'm talking about,” Trump said on Monday.In late August, the CDC told states to begin to prepare distributing a vaccine by Nov. 1. But Surgeon General Jerome Adams said that just because states will be ready to help distribute a vaccine on Nov. 1 does not mean a vaccine will be ready by then."We've always said that we're hopeful for a vaccine by the end of this year or the beginning of next year,” Adams told Good Morning America."We want to make sure states are available to distribute it," he added.The companies signing on the pledge said that the FDA has strict protocols for vaccine candidates. A typical vaccine trial takes one to three years, but the companies believe only a safe and effective vaccine will be granted approval.“FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US,” the companies wrote in the pledge. “FDA’s guidance and criteria are based on the scientific and medical principles necessary to clearly demonstrate the safety and efficacy of potential COVID-19 vaccines. More specifically, the agency requires that scientific evidence for regulatory approval must come from large, high quality clinical trials that are randomized and observer-blinded, with an expectation of appropriately designed studies with significant numbers of participants across diverse populations.” 3296

来源：资阳报